Romapharm SA
5.6 FTEThe score of Romapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +35 % Total assets +16 % Headcount (avg FTE) -23 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Romapharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 19 Apr 2025
- Year ended 31 Dec 2023filed on 03 May 2024
- Year ended 31 Dec 2022filed on 24 Apr 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Romapharm's financial analysis
- Solvency77.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Romapharm
Romapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0456.909.689
- VAT number
- BE0456909689
- Peppol
- Registered · 0208:0456909689 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Dec 1995
- Registered office
- 8670 Koksijde
- Size
- Micro · 5.6 FTE
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Romapharm (SA) has been based in Koksijde since 1995, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 140,883 € and equity of €2.28m; its revenue is not published. With 5.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 77.0%, above the median of its sector (44.2%).
Companies similar to Romapharm
Companies in the same business, of comparable size and area, outside its group.
- Phaverso Retail sale of pharmaceutical products Moorslede · balance sheet €3.28m
- Apotheek An Sofie Stragier Retail sale of pharmaceutical products Bruges · balance sheet €2.66m
- Pharmalorraine Retail sale of pharmaceutical products Aubange · balance sheet €2.26m
- Unidose Pharma Retail sale of pharmaceutical products Izegem · balance sheet €3.90m
- Molleman - DE Coster Retail sale of pharmaceutical products Wingene · balance sheet €2.22m
- Apotheekgroep Zele Retail sale of pharmaceutical products Zele · balance sheet €3.55m
- Pharmacie L BRICLET Retail sale of pharmaceutical products Charleroi · balance sheet €2.03m
- Farcas Retail sale of pharmaceutical products Gavere · balance sheet €1.64m
Frequently asked questions about Romapharm
What is the revenue of Romapharm?
Romapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Romapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0456909689 for Romapharm, if the company is VAT-registered. Its company number (CBE) is 0456.909.689.
Where is the registered office of Romapharm?
According to the CBE register, the registered office of Romapharm is in 8670 Koksijde.
What is the equity of Romapharm?
At the close of the 2025 financial year, the equity of Romapharm amounts to 2,283,595 €, a solvency of 77.0% of total assets.
How many people work at Romapharm?
5.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Romapharm?
The register lists 6 active mandates at Romapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Romapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →